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Inhibition of hydrogen sulfide 
biosynthesis sensitizes 
lung adenocarcinoma to 
chemotherapeutic drugs by 
inhibiting mitochondrial DNA 
repair and suppressing cellular 
bioenergetics
Bartosz Szczesny1, Michela Marcatti1, John R. Zatarain2, Nadiya Druzhyna1, 
John E. Wiktorowicz3, Péter Nagy4, Mark R. Hellmich2 & Csaba Szabo1
Therapeutic manipulation of the gasotransmitter hydrogen sulfide (H2S) has recently been proposed as 
a novel targeted anticancer approach. Here we show that human lung adenocarcinoma tissue expresses 
high levels of hydrogen sulfide (H2S) producing enzymes, namely, cystathionine beta-synthase (CBS), 
cystathionine gamma lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3-MST), in comparison to 
adjacent lung tissue. In cultured lung adenocarcinoma but not in normal lung epithelial cells elevated 
H2S stimulates mitochondrial DNA repair through sulfhydration of EXOG, which, in turn, promotes 
mitochondrial DNA repair complex assembly, thereby enhancing mitochondrial DNA repair capacity. 
In addition, inhibition of H2S-producing enzymes suppresses critical bioenergetics parameters in lung 
adenocarcinoma cells. Together, inhibition of H2S-producing enzymes sensitize lung adenocarcinoma 
cells to chemotherapeutic agents via induction of mitochondrial dysfunction as shown in in vitro and  
in vivo models, suggesting a novel mechanism to overcome tumor chemoresistance.
H2S is produced in mammalian cells by three distinct enzymes, cystathionine beta-synthase (CBS), cystathionine 
gamma lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3-MST); during methionine/transsulfuration 
pathway1–3. Deregulation of either H2S production and/or its downstream actions have been implicated in the 
pathophysiology of several diseases, including cardiovascular disease, shock, inflammation, diabetes, metabolic 
syndromes and neurodegeneration4–11. In connection with cancer, we have previously showed a marked increase 
in the expression of CBS in colorectal cancer cells (compared to the surrounding normal mucosal margin), which 
was also recapitulated in multiple colon cancer cell lines12. ShRNA-mediated silencing, as well as pharmacological 
inhibition of CBS caused a significant inhibition of the proliferation of colon cancer cells in vitro and in vivo (in 
tumor-bearing nude mice). Also, silencing or inhibition of CBS suppressed cellular bioenergetics of the colon 
cancer cells12. The importance of the CBS/H2S in the promotion of cell proliferation and cellular bioenergetics 
has subsequently been confirmed in ovarian cancer13 and breast cancer14. H2S generated by overexpressed CSE, 
has been implicated in melanoma15. In addition a rapidly increasing body of literature implicates the endoge-
nously generated H2S to vascular relaxation and angiogenesis, cell proliferation, mitochondrial function, and cell 
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survival - all important factors in cancer biology16–22. However, the mechanisms by which intra-tumor H2S main-
tains cancer cell viability are incompletely understood. Here we investigated unique roles of H2S in maintenance 
of the critical mitochondrial functions involved in chemoresistance of lung adenocarcinoma cells.
Results
Lung adenocarcinoma tumors and cultured cells express high level of H2S-producing 
enzymes. We compared human lung adenocarcinoma samples to matched adjacent normal lung tissue and 
detected significantly higher protein levels of all three known H2S-producing enzymes, namely, CBS, CSE and 
3-MST (Figs 1A and S1A,B). This was associated with an increased capacity of these tissues to produce H2S, as 
detected by the H2S-specific fluorescent probe, 7-azido-4-methylcoumarin (AzMC) (Fig. 1B). Increased expres-
sion of the various H2S-generating enzymes, and increased H2S production was also noted in multiple cultured 
lung adenocarcinoma cell lines (A549, H522 and H1944), while lung epithelial cells derived from non-malignant 
tissue (BEAS 2B) showed significantly lower levels of H2S production (Figs 1C,D and S1B). H2S production was 
inhibited by aminooxyacetic acid (AOAA), a pharmacological inhibitor of CBS and CSE23 (Fig. 1D). The high 
levels of endogenous H2S in lung adenocarcinoma cells was further confirmed by fluorescent live cell imag-
ing (Fig. 1E). As expected from the roles of CBS and CSE in the transsulfuration pathway, AOAA induced the 
Figure 1. Lung adenocarcinoma cells generate enhanced levels of H2S. (A) The relative protein level of CBS, CSE 
and 3-MST and (B) production of H2S in human lung adenocarcinoma tumors (T, n = 20) and normal adjacent 
lung tissues (N, set as 1; n = 20) measured by Western blot (WB) analysis and using H2S-specific fluorescent 
probe (AzMC). (C) The relative protein level of CBS, CSE and 3-MST analyzed by WB and (D) production of H2S 
generated by extracts of normal lung epithelial (BEAS 2B, set as 1) and lung adenocarcinoma (A549, H522, H1944) 
cells in the absence or present of CBS/CSE inhibitor, AOAA (100 μ M). (E) The endogenous levels of H2S in BEAS 
2B and H1944 cells stained with AzMC. Data are mean ± S.E.M. of at least three independent WB analysis and H2S 
detection. Representative images of three independent experiments are shown *P < 0.05, **P < 0.01 (based on two-
tailed Student’s t-test for pairwise comparison).
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accumulation of serine and homocysteine and decreased cystathionine levels in AOAA-treated A549 cells (Fig. S1C). 
The remainder of H2S production is likely attributed to 3-MST activity (Fig. 1D). Together, these data revealed 
the high expression of H2S-generating enzymes, and increased production of H2S in lung adenocarcinoma when 
compared to normal lung tissue and epithelial cells.
Repair of the mitochondrial DNA is regulated by H2S. Mitochondrial DNA (mtDNA) encodes an 
essential set of proteins to maintain oxidative phosphorylation24. Although, somatic mutations in mtDNA in 
various cancers have been suggested to play a role in a selective advantage during oncogenesis25–27, a recent study 
showed that cancer cells with severe mtDNA damage lost tumorigenic potential because of a failure of respira-
tory functions28. Here we compared the DNA integrity in human lung adenocarcinomas with the adjacent lung 
tissue by the long amplicon PCR assay (LA-qPCR)29. Significantly higher integrity of the mtDNA (less DNA 
breaks) was detected in human lung adenocarcinoma tumors, when compared to matching lung adjacent tissue 
(Figs 2A and S2A) with no difference in nuclear DNA (Figs 2B and S2B). Higher number of the mtDNA cop-
ies was also detected in adenocarcinoma samples (Fig. S2C). Together, we detected more copies of mtDNA in 
adenocarcinoma tumors with much better preserve mtDNA integrity (less DNA breaks). However, there were 
more DNA breaks in the mtDNA but less in the nuclear DNA in cultured lung adenocarcinoma cells (A549 and 
H1944), when compared to normal BEAS 2B cells (Fig. 2C). To solve this discrepancies, we evaluated the extent 
of intrinsic reactive oxygen species (ROS) production by measuring the level of mt-specific superoxide using 
MitoSOX; higher ROS signal intensity was observed in A549 and H1944 cells in comparison to BEAS 2B cells 
(Fig. 2D). This was further supported by observed higher proton leak, a by-product of oxidative phosphorylation, 
in A549 and H1944, when compared to BEAS 2B cells (Fig. 2E). To assess the role of enhanced endogenous H2S 
biosynthesis on DNA integrity, lung cancer-derived and non-tumor derived epithelial cells were treated with 
increasing concentration of glucose oxidase (GOx; in the presence of glucose in culture media GOx generates low, 
continuous levels of hydrogen peroxide). The integrity of the mtDNA was better preserved in GOx-treated A549 
and H1944 cells when compared to BEAS 2B (Fig. 2F); nuclear DNA in these conditions was largely unaffected 
(Fig. S2D). We have recently reported that a mitochondria-targeted H2S donor (AP39) protects mtDNA integ-
rity in endothelial cells subjected to oxidative stress16,30. To test whether endogenous H2S production stimulates 
mtDNA repair in lung adenocarcinoma cells, we monitored the effect of inhibition of CBS/CSE on the integrity 
of mtDNA and nuclear DNA. The results show that after the pharmacological blockade of tumor H2S production, 
a time-dependent accumulation of DNA damage in the mtDNA (but not in the nuclear DNA) develops in A549 
cells (but not in BEAS 2B cells) (Figs 2G and S2E). In addition, inhibition of H2S biosynthesis sensitized A549 
cells to oxidative mtDNA damage (Fig. 2H). SiRNA-mediated depletion of CSE, CBS, and 3-MST or treatment 
with CSE-specific inhibitor, D,L-propargylglycine (PAG)23, also reduced repair rate of the mtDNA (Figs 2I–K 
and S2F,G). The oxidative mtDNA damage was prevented by supplementation of A549 cells with mt-specific H2S 
donor, AP39 (Fig. S2H,I). To rule out possible effect of accumulation of serine and homocysteine in cells treated 
with AOAA on DNA integrity (Fig. S1C), we incubated A549 cells with serine and homocysteine, and measured 
DNA integrity after 24 h; no significant changes were detected for both genomes (Fig. S2J). Together, our data 
show that repair of the mtDNA is enhanced by H2S.
H2S enhance formation of mitochondrial DNA repair complex. Oxidative stress enhances the for-
mation of DNA repair proficient complexes in the mitochondria31. Here, we monitored the binary interactions 
of the mt-specific DNA repair enzymes EXOG and DNA Polymerase gamma (PolG) and, for comparison, two 
selected nuclear-specific DNA repair enzymes (FEN1 and PolB)32,33. The interaction between EXOG with APE1, 
PolG or Lig3, but not between nuclear-specific DNA repair enzymes FEN1 and PolB, was markedly reduced by 
H2S biosynthesis inhibition in lung adenocarcinoma (but not in normal epithelial cells) (Fig. 2L). To provide 
direct evidence of the importance of H2S in observed integrations between mt-specific DNA repair enzymes; 
the interaction between EXOG with APE1 or Lig3 was restored by pharmacological replacement of mitochon-
drial H2S in A549 cells treated with AOAA (Fig. S2K). Using mass spectrometry we identified Cys 76 (C76) of 
EXOG to be post-transnationally modified (sulfhydrated) by oxidized metabolites of H2S (Fig. S3A,B). Next, we 
accessed the interaction of WT EXOG or mutant EXOG (C76A) with APE1, using a co-immunoprecipitation 
(IP) approach. These studies showed a detectable interaction of WT EXOG with APE1 that was enhanced by 
treatment with the H2S donor, NaHS. In contrast, the interaction of mutant EXOG with APE1 was significantly 
lower and insensitive to regulation by NaHS (Fig. S3C). Together, our data provide evidences about critical role of 
H2S in formation of mtDNA-specific repair complexes in lung adenocarcinoma cells.
H2S maintain cellular bioenergetics in lung adenocarcinoma cells. Since mtDNA integrity is essen-
tial to maintain cellular bioenergetics34, we have evaluated the bioenergetic function of cultured lung cells. As 
expected, higher basal and maximal mitochondrial respiration was detected in A549 and H1944 cells, when 
compared to BEAS 2B cells (Fig. 3A,B). Moreover, inhibition of H2S production reduced all major bioenergetic 
parameters in A549 cells; these effects were reversed by AP39 (Fig. 3C,D). Importantly, BEAS 2B cell bioener-
getics were insensitive to inhibitors of H2S production (Fig. 3E). No changes in bioenergetics parameters were 
detected in A549 cells treated with various concentration of serine and homocysteine (Fig. S3D). From these data, 
we conclude that lung adenocarcinoma cells are protected from mtDNA damaging agents (e.g., ROS) through the 
H2S-dependent enhancement of mtDNA repair mechanisms, resulting in cancer cell-specific improvements in 
mitochondrial electron transport and cellular ATP generation.
Inhibition of H2S-producing enzymes sensitize lung adenocarcinoma cells to chemotherapeutic 
drugs in vitro and in tumor bearing mouse model. EXOG is essential for mtDNA repair; if its activity 
is blocked, apoptosis develops32,35, strongly indicates that accumulation of DNA breaks in mtDNA alone induce 
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Figure 2. H2S mediates enhanced mtDNA integrity in lung adenocarcinoma cells. (A,B) Comparison of 
the mitochondrial and nuclear DNA integrity in human lung adenocarcinoma tumors (T, n = 20) and normal 
adjacent lung tissue (N, set as 100%; n = 20). (C) Mitochondrial and nuclear DNA integrity in cultured lung 
epithelial cells (DNA integrity in normal BEAS 2B cells was set as 100%). (D,E) Relative level of oxidative 
stress measured by MitoSOX Red staining and proton leak-linked to oxygen consumption rate (OCR) profile. 
(F) Integrity of the mtDNA after 1 h challenge with increasing concentration of glucose oxidase (GOx) (DNA 
integrity in untreated cells was set as 100%). (G) MtDNA integrity in cells treated with 1 mM AOAA, an 
inhibitor of CBS and CSE. (H) MtDNA integrity in A549 cells treated with AOAA (1 mM) and GOx for 1 h. 
(I–K) Restoration of the mtDNA integrity in A549 cells transiently depleted from CBS, CSE or 3-MST (DNA 
integrity measured immediately after GOx treatment was set as 1). (L) Binary interaction between DNA repair 
enzymes in the presence or absence of AOAA (300 μ M) measured by proximity ligation assay (PLA). Data are 
mean ± S.E.M of at least three independent analysis of DNA integrity run in technical triplicates. Representative 
images of three independent experiments are shown *P < 0.05, **P < 0.01 (based on two-tailed Student’s t-test 
for pairwise comparison).
www.nature.com/scientificreports/
5Scientific RepoRts | 6:36125 | DOI: 10.1038/srep36125
cell death. We tested the effect of H2S biosynthesis inhibition on the viability of lung cancer cells; A549 and H1944 
cells in comparison to BEAS 2B, were significantly less resistant to increasing concentration of AOAA as meas-
ured with colony formation assay (Fig. 4A), suggesting essentiality of H2S in survival of lung adenocarcinoma 
cells. Also proliferation of particularly A549 cells was reduced at 48 h in the presence of AOAA (Fig. 4B). We 
hypothesized that inhibition of H2S-generating enzymes, would sensitize lung adenocarcinoma cells to chemo-
therapeutic drugs. Cellular viability determined by the release of LDH (due to necrotic cell death) showed that 
although AOAA-treatment alone did not result in decreased viability of either BEAS 2B and A549 cells, in combi-
nation with camptothecin (CPT, DNA topoisomerase I inhibitor) a concentration-dependent decrease in viability 
of A549 (but not BEAS 2B) cells was observed (Figs 4C and S4A). Similarly, treatment with another chemother-
apeutic drug, oxaliplatin, in combination with AOAA, resulted in decreased cellular viability of A549 (but not 
BEAS 2B) cells (Fig. S4B). The combination of AOAA and CPT also resulted in time-dependent, synergistic 
increase in apoptosis (Fig. 4D), mtDNA damage (Fig. 4E) and decrease oxygen consumption linked with ATP 
synthesis (Fig. 4F) in A549 cells. In order to provide additional evidence that reduced level of endogenous H2S 
sensitize A549 cells to chemotherapeutic drugs, silencing of CBS also increased LDH release in CPT-treated A549 
cells in concentration dependent manner (Fig. 4G).
Finally, we investigated the effect of inhibition of H2S biosynthesis in a mouse model of A549 xenografts. 
Although, tumor volume was reduced in mice treated daily with 9 mg/kg AOAA; its growth resumed when 
AOAA treatment discontinued and animals were switched to vehicle treatment (Fig. S5A). Next, we reduced 
the dose of AOAA to 3 mg/kg and investigated the effect of combined treatment with irinotecan. We noted the 
greatest reduction of tumor growth-rate in animals treated with the combination of AOAA and CPT (Figs 5A,B 
and S5B,C). Similarly, the most pronounced degree of DNA damage was seen in tumors of mice treated with the 
AOAA/irinotecan combination (Fig. 5C,D). Comprehensive diagnostic blood profile analysis showed no signs of 
organ injury in mice treated with the AOAA/irinotecan combination (Table S1).
Discussion
The above data show that lung adenocarcinoma cells upregulate their H2S biosynthesis and use it: (i) to increase 
the repair capacity of the mtDNA and (ii) to support cellular bioenergetic function; both critical for maintenance 
of the mitochondrial and cellular homeostasis. Consequently, pharmacological inhibition of H2S production in 
tumor cells induces mitochondrial dysfunction by reduction of DNA repair capacity in the mitochondria, which 
sensitizes lung adenocarcinoma cells to chemotherapeutic drugs (Fig. 5E). This approach may form the basis of 
Figure 3. H2S is critical for maintaining bioenergetics of lung adenocarcinoma cells. (A) Changes in 
profiles of oxygen consumption rate (OCR) of BEAS 2B, A549 and H1944 cells (oligo; oligomycin, an inhibitor 
of ATP synthase; FCCP; carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, mitochondrial oxidative 
phosphorylation uncoupler; AA, antimycin A, ROT, rotenone, inhibitors of complex III and I). (B) Comparison 
of cellular bioenergetics parameters of BEAS 2B, A549 and H1944 cells based on OCR. (C,D) Time dependent 
changes in cellular bioenergetics parameters in A549 and BEAS 2B in response to 300 μ M AOAA treatment 
based on OCR. (E) Changes in cellular bioenergetics parameters in A549 treated with 300 μ M AOAA, 100 nM 
AP39 or both for 5 h based on OCR. Data are mean ± S.E.M of at least three independent experiments. 
*P < 0.05, **P < 0.01 (based on two-tailed Student’s t-test for pairwise comparison).
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novel combination approaches in the experimental therapy of lung adenocarcinoma and increase therapeutic 
index of chemotherapeutic drugs, and reduce side effects.
Mammalian cell has hundreds of mitochondria, each containing approximately 10 copies of 16.5 kb 
plasmid-like mitochondrial DNA (mtDNA)24. The mutation rate of human mtDNA is 20- to 100-fold higher 
that in the nuclear DNA36,37. One of the reasons is constant challenge of the mtDNA by oxidants generated as 
a by-product of mitochondrial oxidative phosphorylation. Also, the repair mechanisms of the mtDNA, in con-
trast to the nuclear DNA, are limited, due to lack of nucleotide excision repair and lack of back-up for the sole 
DNA polymerase gamma (PolG) and DNA ligase 3; both essential for the correct repair and replication of the 
mtDNA33. This means that the mtDNA is more susceptible to genotoxic agents than the nuclear DNA, as demon-
strated by our group and other investigators in various cell types16,35,38,39. It is generally accepted that DNA base 
excision/single strand break repair (BER/SSBR) pathway is the predominant DNA repair mechanism within 
the mitochondria33. There are only two mitochondria-specific BER/SSBR enzymes identified so far: EXOG and 
PolG32–34, the remaining enzymes are shared by the mitochondria and the nucleus.
Mitochondria research, including studies of maintenance of the mtDNA integrity were for a long time 
neglected in cancer field since upregulation of glycolysis as a major source of energy was proposed, known as a 
Warburg effect. However, the functional consequence of decreased mtDNA integrity (accumulation of mtDNA 
damage) for the survival of the cancer cell has been recently re-defined by several studies. In contrast to the 
nuclear DNA, where DNA instability is one of the hallmark of cancer cells (increase rate of mutations is used by 
the cancer cell to evade the body’s antitumor mechanisms, and to develop resistance against anticancer agents); 
with respect to mtDNA, the priority of the cancer cell is to maintain its integrity (i.e. to reduce the amount of 
DNA breaks)25,26. It has been recently shown that intact mtDNA is critical for tumorigenic potential28. When the 
integrity of the mtDNA becomes impaired, mitochondrial cell death pathways become activated, the regulation 
of mitochondrial protein expression becomes impaired, the cellular bioenergetic homeostasis becomes impaired, 
and the cell’s viability and survivability is suppressed (reviewed in ref. 40. In fact, mtDNA is so critical for the 
cancer cell, that if the mtDNA is depleted, the cancer cells develop mechanisms to take it up from the host cell, 
in order to replenish their cellular pools28. Some authors even call the mtDNA of the cancer cell “a genetic sanc-
tuary”41. Together, various recent studies indicate the importance of the preservation of the mtDNA integrity 
Figure 4. Inhibition of H2S production sensitize cultured lung adenocarcinoma cells to chemotherapeutic 
drugs. (A) Viability of BEAS 2B, A549 and H1944 cells to inhibitor of CSE and CBS (AOAA). (B) Relative 
proliferation expressed as % of untreated cells after 48 h of 200 μ M of AOAA treatment of cultured lung 
adenocarcinoma cells. (C) Necrotic cell death determined by LDH release of A549 cells treated with AOAA, 
CPT and AOAA/CPT for 24 h (vehicle treated cells were set as 1). (D) Time dependent changes in amount 
of apoptotic cells measured by Annexin V staining of A549 cells treated with 300 μ M AOAA, 300 nM CPT or 
combination of both. (E) MtDNA integrity of A549 cells treated for 24 h with 300 μ M AOAA, 300 nM CPT or 
combination of both. (F) Oxygen consumption of A549 cells treated for 24 h with 300 μ M AOAA, 300 nM CPT 
or combination of both. (G) Necrotic cell death determined by LDH release of A549 cells transiently transfected 
with control or CBS-specific siRNA treated with CPT for 24 h (vehicle treated cells were set as 1). Data are 
mean ± S.E.M of at least three independent analysis of colony formation assay, LDH release, Annexin V staining 
and of DNA integrity run in technical triplicates. Representative images of three independent experiments are 
shown *P < 0.05, **P < 0.01 (based on two-tailed Student’s t-test for pairwise comparison).
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(meaning proper mtDNA repair); yet the molecular mechanisms of how mtDNA integrity is preserved in cancer 
cells are poorly defined. Here we are showing for the first time that reduction of the H2S-production in lung 
adenocarcinoma but not in normal lung epithelial cells results in accumulation of the DNA repair intermedi-
ates in the mitochondrial but not nuclear DNA. There are only a limited number of published data connecting 
H2S with mtDNA transactions. Using a recently developed mitochondrial-specific H2S donor, AP3930, we have 
shown previously that mitochondria-specific H2S delivery significantly reduces amount of mtDNA damaged 
induced by oxidative stress in cultured endothelial cells, suggesting a stimulatory role of H2S in process of the 
mtDNA repair16. Another report demonstrated that cells deficient in H2S production (due to CSE deficiency), 
have reduced number of mtDNA copies42. Thus - although a correlation between H2S and mtDNA damage/repair 
has been implicated - the molecular mechanisms of how H2S regulates the integrity of the mtDNA, and how these 
processes are important for the tumorigenic potential of cancer cells is currently unknown. Here we showed for 
the first time that H2S directly regulates repair capacity of the mitochondria. Our data indicate that H2S supports 
formation/stabilize mitochondrial DNA repair complexes and thus increases DNA repair capacity within mito-
chondria. We have shown earlier an active process of formation of the mitochondrial DNA repair complexes in 
response to oxidative stress31. Now we identified critical cysteine residue on EXOG modify by H2S which in turn 
regulates binary interaction with APE1. Both enzymes are critical in DNA end-processing step during BER/SSBR. 
We showed previously that accumulation of unrepaired DNA intermediates, mostly single strand breaks in the 
mtDNA induce cell death32.
In light of recently emerging data, the role of H2S in the regulation of cellular bioenergetics has been also 
completely re-evaluated. In contrast to the earlier observations demonstrating the toxicity of exogenously added 
H2S as an inhibitor of mitochondrial cytochrome c oxidase (complex IV), recent data indicate that low, physi-
ological concentrations of H2S (produced by endogenous, enzymatic sources) has a stimulatory effect on cellu-
lar bioenergetics. Physiologically, H2S acts as an electron donor and a stimulator of bioenergetics43. Hepatoma 
cells with depleted 3-MST (a constitutive mitochondrial H2S-generating enzyme) exhibit reduced bioenergetics 
parameters43. We have shown that nanomolar concentrations of the mitochondrial H2S donor, AP39, stimulate 
cellular bioenergetics in cultured endothelial cells16. These data are consistent with a biphasic biological H2S 
dose-response, where many effects of H2S at low concentration are beneficial, while at higher concentrations, tox-
icity develops [reviewed in refs 44 and 45]. However, the role of H2S in regulation of bioenergetics in lung cancer 
Figure 5. Combination of inhibition of H2S-producing enzymes and chemotherapeutic drugs accelerate 
decreasing of tumor volume in mouse model. (A,B) Tumor volumes of mice injected SQ with A549 cells 
treated with vehicle (PBS), AOAA (3 mg/kg), irinotecan (3 mg/kg) and both (n = 8 for each group). (C,D) DNA 
integrity measured in tumors of the same animals. (E) Schematic graph of summary of obtained results. Data 
are mean ± S.E.M. DNA integrity was run in technical duplicates. *P < 0.05 (based on two-tailed Student’s t-test 
for pairwise comparison).
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cells has not yet been investigated. Our data suggest that enhanced amounts of H2S in lung adenocarcinoma cells 
is also used to maintain cellular bioenergetics.
The enhanced H2S biosynthesis demonstrated in the current report selectively supports vital functions of 
lung adenocarcinoma cells, compared to normal lung epithelial cells. We hypothesized that pharmacological 
inhibition of H2S-generating enzymes or reducing intracellular level of H2S by specific scavenger would induce 
mitochondrial dysfunction which in turn would sensitize lung adenocarcinoma cells towards chemotherapeutic 
drugs. Our in vitro and in vivo data confirm that this is a case. Combination of CBS/CSE inhibitor with com-
monly used chemotherapeutic agents campothecin or oxaliplatin greatly increases cell death of cultured cells 
and reduced tumor volume in a mouse model. Aminooxyacetic acid (AOAA) - commonly used inhibitor of CBS 
and CSE - inhibits multiple PLP-dependent enzymes including several oxidoreductases, transferases, hydrolases 
or isomerases46. Therefore, there is a great need to develop novel, more specific inhibitors for H2S-producing 
enzymes, particularly for CSE and CBS, in context of lung adenocarcinoma. Another approach may be to develop 
mitochondria-specific H2S scavengers in order to reduce mitochondria DNA repair capacity and oxidative phos-
phorylation to induce mitochondrial dysfunction in cancer cells and to sensitize specifically cancer cells to chem-
otherapeutic drugs.
Experimental Procedures
Cell culture. The normal lung epithelial cells BEAS 2B (ATCC CRL-9609; Manassas, VA), and lung adeno-
carcinoma cells A549 (ATCC CCL-185), NCI-H522 (ATCC CRL-5810) and NCI-H1944 (ATCC CRL-5907), 
were maintained in RPMI 1640 media supplemented with 10% fetal bovine serum and 100 IU/ml penicillin and 
100 μ g/ml streptomycin at 37 °C in 5% CO2.
Human lung adenocarcinoma tumors and normal adjacent lung tissue. 20 pairs of lung adenocar-
cinoma tumors and normal adjacent lung tissue was obtained from Lung Cancer Biospecimen Resource Network, 
University of Virginia Health System, Charlottesville, VA. The experimental protocol was approved by the UTMB 
Institutional Review Board (IRB), and this study was conducted in compliance with ethical and safe research 
practices involving human tissues.
Animal xenograft model of human lung cancer. All animal studies were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Texas Medical Branch and were carried out in 
accordance to the approved guidelines. Athymic nude Balb/c male and female mice (8–10 weeks) purchased 
from Charles Rivers (Wilmington, MA) were injected subcutaneously in either the right or left dorsum with 
5–8 × 106 A549 cells as described12. 25 or 28 days later, mice were randomized and subcutaneous (SQ) injection 
of phosphate buffered saline (PBS) as a vehicle, AOAA (3 or 9 mg/kg/day), irinotecan (3 mg/kg) or combination of 
AOAA/irinotecan (3 mg/kg and 3 mg/kg). Tumor dimensions were measured 2 times per week transcutaneously 
using a caliper and tumor volume was calculated using the formula π /6 (HxWxL).
Detection of H2S and mitochondrial oxidant production in live cells. 40,000 of BEAS 2B, 
A549 and H1944 cells were seeded in Lab-Tek II chamber coverglass system (Nalgen Nunc International) 
and incubated at 37 °C and 5% CO2 humidified incubator overnight. The cells were loaded with 10 μ M of 
7-azido-4-methylcoumarin (AzMC, Sigma) for 2 h to detect endogenous H2S or with 5 μ M of MitoSOX Red dye 
(Invitrogen) for 10 min to detect mitochondrial superoxide production. Cells were washed three times with PBS 
and dye’s specific fluorescence was visualized using Nikon eclipse 80i inverted microscope with Photometric 
CoolSNAP HQ2 camera and NIS-Elements BR 3.10 software.
Measurement of H2S production in cell homogenates. The cultured BEAS 2B, A549, H522 and H1944 
cells were washed twice with PBS and homogenized in NP40 lysing buffer (1% NP40, 150 mM NaCl, 50 mM 
Tris-Cl, pH 8.0) on ice for 30 minutes. The protein concentration determined with Lowry reagent (Bio-Rad) using 
BSA as a standard of the extract was adjusted to 10 mg/ml. Cell homogenates (20 μ l) were incubated in 96-well 
plates with 5 μ M PLP and 2.5 mM of each L-cysteine and homocysteine, and H2S production was monitored fol-
lowing fluorescent signal of AzMC (10 μ M) at 450 nM for 2 h.
Cell proliferation. For assessment of cell proliferation, the xCELLigence system (Roche) was used. Briefly, 
8,000 of BEAS 2B, A549 or H1944 cells per well were seeded on a E-plate 96, a specially designed 96-well microti-
ter plate containing interdigitated microelectrodes to non-invasively monitor the cell proliferation by measuring 
the relative change in the electrical impedance of the cell monolayer. 24 h after initial seeding, cells were treated 
with 300 μ M of AOAA and proliferation monitored for 48 hours.
Measurement of mitochondrial and nuclear DNA integrity. To measure DNA integrity, we used 
gene-specific semi-quantitative PCR assays using LongAmp Taq DNA Polymerase (New England BioLabs) as 
described29. Briefly, total DNA was isolated using DNase Blood and Tissue Kit (QIAGEN). Damage to nuclear 
DNA was estimated by quantification of the PCR amplification of the 10 kb nuclear-specific DNA fragment 
using PicoGreen fluorescent dye to detect double-stranded DNA (Quant-iT™ PicoGreen, Molecular Probe). 
Damage to the mitochondrial DNA was estimated by quantification of the PCR amplification of the 8.9 kb 
mitochondrial-specific DNA fragment using PicoGreen staining. Obtained data was normalized by the PCR 
amplification of 211 bp mitochondrial genome-specific fragment for correction of the multiple copies of the mito-
chondrial genome. Preliminary assays were carried out to ensure the linearity of PCR amplification with respect 
to the number of cycles and DNA concentration. Note, decreased integrity of the DNA mean increasing amount 
of DNA breaks detected in amplified region.
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Proximity Ligation Assay (PLA). PLA was performed using Duolink In situ Kit (SIGMA) according to 
the manufacturer’s recommendations with following a pair of primary antibodies raised in two different species: 
rabbit (r) EXOG (SIGMA), mouse (m) APE1 (Novus Biologicals), m PolG, m Lig3, r FEN1, m PolB (all from 
GeneTex). Briefly, cells were fixed and permeabilized with 4% paraformaldehyde, 0.2% Tween-20 in PBS for 
20 min at room temperature. After blocking for 1 h at room temperature cells were probed with primary anti-
bodies (at 1:200 dilution) overnight at 4 °C. Signal detection and amplification was performed per manufacturer’s 
instructions. Images were captured using Nikon eclipse 80i inverted fluorescent microscope with Photometric 
CoolSNAP HQ2 camera and NIS-Elements BR 3.10 software.
Bioenergetic analysis in cultured cells. The XF24 Extracellular Flux Analyzer (Seahorse Bioscience, 
Agilent Technologies) was used to measure bioenergetic function. Oxygen consumption rate (OCR) after oligo-
mycin (1.5 μ g/ml) was used to assess ATP production rate, OCR after FCCP (0.5 μ M) to assess maximal mito-
chondrial respiratory capacity, OCR after antimycin A (2 μ g/ml) and rotenone (2 μ M) were used to inhibit the flux 
of electrons through complex III and I, to detect residual non-mitochondrial oxygen consumption rate, which is 
considered to be due to cytosolic oxidase enzymes. OCR linked with proton leak was quantified by substation of 
OCR after antimycin/rotenone from OCR after FCCP. OCR was normalized by μ g of protein extract in each well.
LDH assay. Lactate dehydrogenase (LDH) release was used as a cytotoxicity assay, and as a secondary meas-
urement for determination of necrotic cell death. The changes in absorbance were read kinetically at 492 nm for 
15 min on a monochromator-based reader (Powerwave HT, Biotek) at 37 °C. LDH activity values are shown as 
Vmax for kinetic assays in mOD/min.
Colony formation assay. 200 cells of BEAS 2B, A549 or H1944 cells were seeded on 6 well plates. After 
24 h of incubation at 37 °C in 5% CO2 media was change to containing various concentration of AOAA. Colonies 
were counted after 10 days using 1% crystal violet in 50% methanol. Each experiment was repeated 3 times with 
technical triplicates.
Determination of apoptotic cell death. Amount of Annexin V positive cells was determined using PE 
Annexin V Apoptosis Detection Kit (BD Biosciences) according to manufacture’s recommendation. Briefly, A549 
cells were treated with 300 μ M AOAA, 300 nM CPT or combination of both for 1, 3, 9 and 24 h. Number of 
Annexin V positive cells was determined using EasyCyte™ Plus Flow Cytometry System (Guava).
Transient depletion with siRNA. A549 cells were transfected with 40 nM siRNA specific for CBS 
and 3-MST (#7882, #s194616, Ambion, Life Technologies) and 80 nM siRNA for CSE (#10674, Ambion, Life 
Technologies) or control siRNA using Lipofectamine 2000 (Invitrogen) per the manufacturer’s protocol. To opti-
mize the siRNA concentration for maximal target depletion, preliminary transfections were carried out with 
10–100 nM for each siRNA. The level of depletion was calculated by densitometric analysis of Western blots 
relatively to loading control of three independent experiments. Cells with 80–90% depletion measured 48 h 
post-transfection were used in subsequent experiments.
Statistical analysis. Data are shown as means ± standard error of the mean (SEM). Statistical analysis was 
performed with Prism G, based on two-tailed Student’s t-test for pairwise comparison; *p < 0.05 and **p < 0.01 
represent statistically significant differences from control.
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